Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C

被引:102
作者
Boeker, KHW
Haberkorn, CI
Michels, D
Flemming, P
Manns, MP
Lichtinghagen, R [1 ]
机构
[1] Hannover Med Sch, Dept Clin Chem, D-30623 Hannover, Germany
[2] Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30623 Hannover, Germany
[3] Hannover Med Sch, Inst Pathol, D-30623 Hannover, Germany
关键词
liver disease; hepatitis C; fibrosis; cirrhosis; matrix metalloproteinase; gelatinase MMP; TIMP; hyaluronate; hyaluronic acid;
D O I
10.1016/S0009-8981(01)00730-6
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
Background: Circulating levels of tissue inhibitor of metalloproteinase (TIMP)-1 and matrix metalloproteinase (MMP)-2 are investigated as parameters for the diagnosis of fibrosis in chronic liver disease. We evaluated their diagnostic potential in comparison to hepatic histology, serum hyaluronate and standard liver function tests. Methods: Commercially available ELISA assays were used to study circulating values of TIMP-1 and MMP-2 (Bindazyme(TM), Biotrak(TM), Quantikine(TM)) in patients with chronic hepatitis C (CAH; n = 59), hepatitis C virus-induced cirrhosis (n = 19) and 30 healthy controls. Hepatic histology was evaluated using the Hepatitis-Activity-Index according to Ishak et al. [J. Hepatol., 22 (1995) 696-699], quantifying separately inflammatory activity and fibrosis. Results: Normal ranges for TIMP-1 and MMP-2 values differed for the different assays. Nevertheless, the various assays showed similar diagnostic ability and linear correlation. MMP-2 values were similar in controls and in CAH patients with and without fibrosis, but increased significantly in cirrhosis. TIMP-1 values showed a steady increase from normal to CAH without fibrosis, hepatitis with fibrosis, and cirrhosis. The diagnostic potential of serum MMP-2 to detect fibrosis was low with a sensitivity of 7% in the two assays used and an overall diagnostic efficiency of 56% and 58%. The potential of circulating MMP-2 to detect cirrhosis was higher with sensitivities of 74% and 83% and specificities of 96% and 100%, resulting in a diagnostic efficiency of 92% in the different assays. Plasma TIMP-1 values detect fibrosis with a sensitivity of 52% and 67% and a specificity of 68% and 88% resulting in overall efficiency rates of 68% and 71%, respectively. TIMP-1 values detect cirrhosis with 100% sensitivity but only 56% and 75% specificity. The diagnostic potential of circulating TIMP-1 was similar to that of hyaluronate and better than that of enzymes or albumin values. Conclusion: Plasma values of TIMP-1 and MMP-2 are able to detect cirrhosis with high sensitivity. TIMP-1 values also detect fibrosis with comparable efficiency. Regular determinations of both TIMP-1 and MMP-2 in CAH patients may be used as indicators of increasing fibrosis and the development of cirrhosis. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:71 / 81
页数:11
相关论文
共 26 条
[1]
[Anonymous], 1999, J Hepatol, V30, P956
[2]
ARTHUR MJP, 1995, J HEPATOL, V22, P43
[3]
Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver [J].
Benyon, RC ;
Iredale, JP ;
Goddard, S ;
Winwood, PJ ;
Arthur, MJP .
GASTROENTEROLOGY, 1996, 110 (03) :821-831
[4]
Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation [J].
Benyon, RC ;
Hovell, CJ ;
Da Gaça, M ;
Jones, EH ;
Iredale, JP ;
Arthur, MJP .
HEPATOLOGY, 1999, 30 (04) :977-986
[5]
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[6]
The natural course of chronic hepatitis C: implications for clinical practice [J].
Dusheiko, GM .
JOURNAL OF VIRAL HEPATITIS, 1998, 5 :9-12
[7]
Ebata M, 1997, LIVER, V17, P293
[8]
Hepatitis C virus infection: quality of life and side effects of treatment [J].
Foster, GR .
JOURNAL OF HEPATOLOGY, 1999, 31 :250-254
[9]
HISTOLOGICAL GRADING AND STAGING OF CHRONIC HEPATITIS [J].
ISHAK, K ;
BAPTISTA, A ;
BIANCHI, L ;
CALLEA, F ;
DEGROOTE, J ;
GUDAT, F ;
DENK, H ;
DESMET, V ;
KORB, G ;
MACSWEEN, RNM ;
PHILLIPS, MJ ;
PORTMANN, BG ;
POULSEN, H ;
SCHEUER, PJ ;
SCHMID, M ;
THALER, H .
JOURNAL OF HEPATOLOGY, 1995, 22 (06) :696-699
[10]
Jung K, 1998, CLIN CHEM, V44, P1060